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INTRODUCTION
There have been numerous reports describing
negative growth regulators very recently. The majority
of the work described the isolation and
antiproliferative activity of these molecules. This type
of work and studies on the functions of cell membranes
have provided insight about growth regulation. It
becomes clear that cell growth is controlled not only by
positive growth factors but also by negative growth
factors. However, the biological significance (i.e., the
physiological role) of these substances during cell
proliferation, differentiation or even the development
of the individual species remains to be clarified.
In this thesis, evidence is presented to show that
molecules purified from the surface membrane of bovine
cerebral cortex cells exhibit inhibitory activity on
cell growth. Further evidence is provided to show the
potency of the molecules in antagonizing the activity of
a phorbol ester 12-0-tetradecanoylphorbol-13-acetate
( TPA ) , a strong tumor promoter
.
I. HISTORICAL REVIEW
Cell-cell communication has been of considerable
interest to many biologists. Mammals, in particular,
have evolved nervous and endocrine systems which
function to transmit signals to distal parts of the
organism. Cell-cell interactions between adjacent
cells, on the other hand, also exist. For instance, a
developing embryo would be the most vivid example of this
type. Early observations (Townes & Holfreter, 1955)
pointed out preferential aggregation of the embryonic
cells with their starting tissue type when cells of
ectodermal
, mesodermal or endodermal origin from various
stages of development were dissociated. The results
implied that cells somehow recognized each other.
Indeed, cell-cell communication may be fundamental to
the coordinated living systems of an organism as a whole.
It would be an insurmountable task to study signal
transduction between cells in a whole organism. Studies
of this sort are often complicated by a number of factors
,
such as interactions of different organ systems. It is
very difficult to discriminate between these factors
under most conditions. To circumvent these problems, one
could resort to cell culture as an alternative; it was
soon discovered that cell culture offered many
advantages. It is only feasible to explore molecular and
cell biology when specific type of cells are available in
large quantity and grown in defined conditions. Hence the
findings can be reproduced by other workers. These
advantages of cell culture have outweighed the
disadvantages in the development and application of this
system over several decades. However, care must be taken
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in extrapolating the data from cell culture studies back
to the organism.
Earlier observations Indicated that primary chick
embryo fibroblasts grew in culture as an ordered array of
cells (Abercrombie & Heayman, 1954). These cells
exhibited a decreased rate of proliferation at higher
cell density. Later, Todaro and Green ( 1963 ) grew embryo
fibroblasts from Swiss 3T3 mice. They observed that these
4
cells would not grow at densities greater than 6.0 x 10
cells/ml. Rather, they formed a confluent monolayer . The
observations of restriction of growth in dense culture
led Stoker and Rubin (1967) to propose the term "density
dependent growth inhibition". They observed that
saturation density of cells in culture was constant and
characteristic of each cell line under optimal
conditions. In addition, they emphasized that the term
contact inhibition ought to be strictly reserved for
arrest of movement and should not be confused with cell
division, because the available evidence suggested that
inhibition of movement and of growth were unrelated.
Several hypotheses, however, are postulated to explain
the phenomenon of density dependent growth inhibition
and they are not mutually exclusive. It must be pointed
out that the biochemistry of growth control of cells
involves complex interactions between cells and the
environment. Causal and casual consequences of
observations are very likely intermingled in forming the
hypotheses
. In general , there are three major theories as
follows
:
1. Nutrient Transport Hypothesis: The emphasis is on the
transport of nutrients across the cell membrane as the
key components in growth control
.
2. Soluble Growth Factor Hypothesis: The focus is on some
growth factors or molecules as mediators predominantly
in a positive regulatory control
3. Cell-cell Contact Hypothesis : A concern of the growth
control by components of the cell membrane in contact
that mediate in a negative manner
.
Nutrient Transport
Cell growth requires increased uptake and/or
incorporation of nutrients (e.g., amino acids) into the
cells. It is plausible to assume that some of these
nutrients play a key role in growth regulation. This
theory is simple and no other regulatory molecules are
considered. The observations that subconfluent cultures
were rich in these molecules whereas confluent cultures
lacked these molecules led Holley (1972) to propose that
cell growth was under the control of nutrients. Depletion
of nutrients at higher cell densities accounted for
declined rate of cell proliferation; cells would reach
higher saturation density if increased levels of serum,
amino acids or other nutrients were provided (Todaro &
Green, 1963). These findings supported the important
part of nutrients in growth control
.
Pardee (1971) provided evidence in support of this
theory. It was considered that regulatory molecules
altered the structure of the cell membrane.
Subsequently, the transport of other molecules, such as
amino acids, were changed as well. Growth control was
thus subjected to alteration of functions and structures
of the cell membrane. However, it is very difficult to
pursue the model of nutrient transport. First, it is no
easy job to sort out a variety of nutrients in the
studies. It is almost impossible to follow one-to-one
correspondence between transport of certain nutrients
and the consequential activity in the cell at the
molecular level. For example, the exact mechanism
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involved during the transport of lysine into the cells
and the biochemical consequences is not clear. Second,
more convincing data have been recently emphasized from
studies on growth factors and inhibitors. Holly and
others (1980) have described the isolation of a growth
inhibitor from BSC-1 cells. Recently, Croy and Pardee
(1983) have become interested in studying growth factors
and certain key regulatory proteins in controlling cell
proliferation. Nonetheless, nutrient transport is, at
best , indirectly associated with growth control
.
Soluble Growth Factors
There has been a proliferation of literature on
soluble growth factors recently (Feramisco et al.
,
1985 ) . It is known that cells in culture can be maintained
in a resting state for a long period (Pardee et al.
,
1978). Soluble growth factors, however, stimulate these
quiescent cells and initiate DNA synthesis and cell
division (Heldin & Westermark, 1984). These agents are
hormone-like molecules in function. A number of growth
factors have been isolated and purified (reviewed by
James & Bradshaw, 1984). The amino acid sequence of some
factors has been determined. In addition, cell surface
receptors for these factors were identified and
characterized. These receptors are responsible for the
biological activity of the growth factors.
Tremendous progress has been made in this field.
First, a tyrosine-specific protein kinase activity of
several growth factor receptors was described (Heldin
&
Westermark, 1984). Cohen and his colleagues ( 1982 ) found
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this kinase activity in cell surface membranes from A431
cells, which are rich in epidermal growth factor (EGF)
receptors. The kinase activity was also found in
receptors for insulin (Kasuga et al . , 1982) and
platelet-derived growth factor (PDGF) (Ek et al. , 1982;
Nishimura et al . , 1982). Second, antibodies against EGF
receptors were able to block EGF binding and induced
early and delayed effects of EGF (Schreiber et al .
,
1981 ) , including DNA synthesis . Fab fragments of the same
antibodies induced kinase activity but not DNA synthesis
(Schreiber et al. , 1981) and clustering of Fab-receptor
complexes resulted in induction of DNA synthesis
(Schreiber et al . , 1982). The most important
observations were probably the discoveries that several
growth factors have extremely high homology with
oncogene products. For example, the sis proto-oncogene
encodes the beta-chain of PDGF (Doolittle et al. , 1983;
Waterfield et al . , 1983 ) . The erb-B oncogene product is a
truncated form of the EGF receptor (Downward et al .
,
1984). The fms oncogene product is related to macrophage
colony stimulating factor receptor (Sherr et al., 1985).
These discoveries will provide us some clues in the
quest to understand growth regulation of normal cells and
its aberrant form in transformed cells.
Cell proliferation can also be regulated by a
"negative growth factor". An example is the substance
called chalone. Chalones which are hormone-like
molecules of molecular weight 5 , 000 to 50 , 000 inhibit DNA
synthesis of cells in culture (Houck et al . , 1977).
Chalones were isolated from different cell types,
however, further purification and characterization of
these molecules remains to be done.
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Cell-cell Contact
It is conceivable that growth inhibition is due to
cell-cell contact between adjacent cells involving
receptors. Growth inhibitor, either in secreted form as
mentioned previously or membrane-bound form, is involved
in cell proliferation. Mild protease treatment of
confluent 3T3 cells resulted in another round of mitosis
,
suggesting that the growth inhibitors were removed in the
treatment (Burger, 1970). However, the exact mechanism
of action of proteases is not known. Koch (1974) showed
that some cell surface molecules removed from HeLa cells
exhibited inhibitory activity for protein synthesis.
Treatment of subconfluent 3T3 cells with extracts of
membrane components from confluent 3T3 cultures




1978). DNA synthesis of simian virus 40-transformed
3T3 (SV3T3) cells, in contrast, was not affected by the
same treatment. Extracts from SV3T3 were not effective in
inhibiting DNA synthesis of growing 3T3 or SV3T3 cells.
These early discoveries have provided directions to
study growth inhibitors more extensively. Various
sources and the experimental evidence of a negative
growth factor will be discussed.
Hypothalamus-Pituitary
Hypothalamus and pituitary tissues are good sources
of different hormones. Crude extracts of these tissues
were fractionated and several fractions exhibited growth
inhibitory activity in various cell types (Redding &
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Schally, 1982). Boiling of the material did not
inactivate the activity whereas treatment with some
proteases abolished the inhibitory effect. This
substance has not been purified to homogeneity.
Cerebral Cortex
Growth inhibitors, which were polypeptides in
nature and isolated from cerebral cortex cells, were
shown to inhibit protein synthesis and cell division.
Material from mouse brain (Kinders et al . , 1980) and
bovine brain (Kinders & Johnson, 1982) shared similar
biological activities and the bovine material inhibited
cell growth of normal but not transformed cells. The
bovine material contained a major species of molecular
weight 18,000 and a minor species of 16,000. Very
recently, another bovine growth inhibitor was purified
as a result of a new purification procedure ( Sharifi et
al
. , 1986) sharing many physical and biological
properties with the previous bovine inhibitor. The
latest purified molecule differed from the previous
molecule in several properties. For example, the new
inhibitor with pi 3.0, bound to diethylaminoethyl (DEAE)
ion exchange column and a Limulus polyphemus lectin
column but not to an Ulex europaeus lectin column. The old
bovine molecule with pi 8.1, bound to Ulex and
carboxymethyl (CM) ion exchange resin, but not to DEAE.
Interactions between this growth inhibitor of pi 3.0 and
tetradecanoylphorbol ester (Chou et al . , 1987), EGF
(Bascom et al
. , 1986) and bombesin (Sharifi et al., in
preparation) were explored. Binding of the molecule to




Another source of proliferation inhibitor has been
isolated from the liver (McMahon et al., 1982). This
hepatic growth inhibitor was purified to homogeneity
yielding a polypeptide of molecular weight 26,000 and pi
4 . 65 . The active material inhibited growth of liver cells
only while hepatoma cells were not inhibited. No other
type of cells were tested for growth inhibition.
Mammary Gland
A growth inhibitor was purified from bovine mammary
gland (Bohmer et al . , 1984). This inhibitor was a
polypeptide of molecular weight 13,000 and inhibited
cell division of Ehrlich ascites mammary carcinoma
cells. So far no other cells were tested for growth
inhibition; the inhibition was antagonized by insulin,
epidermal growth factor or low levels of fetal calf
serum.
Platelet
Two growth inhibitors isolated from platelets have
been described. The partially purified material
inhibited endothelial cell division and DNA synthesis
(Brown & Clemmons, 1986). The material had a molecular
weight of 35,000 to 40,000 and was heat labile. Treatment
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with proteolytic enzymes inactivated the hiological
activity. Interestingly, another molecule purified from
platelets was beta-transforming growth factor
(beta-TGF) (Assoian et al
. , 1983 ). Beta-TGF is a protein
composed of two 12,500 subunits linked by disulfide
bonds. Beta-TGF inhibited DNA synthesis of normal rat
kidney cells (Roberts et al . , 1985). Beta-TGF has also
been isolated from placenta (Frolik et al.
, 1983).
BSC-1 Cells
Growth inhibitors have been isolated from confluent
BSC-1 cultures (Holley et al . , 1980). The material was
active on BSC-1 cells, but did not inhibit the growth of
3T3 mouse embryo fibroblasts or human skin fibroblasts.
Recently, it was shown that the growth inhibitor from




1984). In addition, a dual regulation of cell growth
was reported for beta-TGF (Roberts et al . , 1985).
Experiments on Fisher rat fibroblasts transfected with
c-myc showed enhancement of colony formation by beta-TGF
in one case and decrease in another case. The data were
interpreted that the effects of beta-TGF on cells were
not a function of the molecule itself, but rather of the
entire set of growth factors involved and/or their
receptors in response to the treatment.
3T3 Cells
Growth inhibitors isolated from quiescent Swiss 3T3
(Hsu & Wang, 1986) in culture media and BALB/c 3T3 in
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membrane-bound form (Datta & Natraj , 1980) were
reported. These substances, in general, inhibited DNA
synthesis of subconfluent cultures. Purification of
these molecules remains to be shown.
Interferon (IFN)
Interferons were first identified by their ability
to protect cells from virus infection (Isaacs &
Lindenmann, 1957). Early work in this area also showed
that these molecules inhibited growth of certain cells
(Paucker et al
. , 1962). Mice injected with tumor cells
showed a slower rate of tumor growth when they were
simultaneously treated with IFN (Gresser & Bourali,
1970). Different experimental models were used for
studying IFN and various degrees of sensitivity to growth
inhibition were reported (Clemens & McNurlan, 1985). In
general, human gamma-IFN (immune IFN) is a more potent
inhibitor of cell growth (Crane et al.
, 1978) and mouse
gamma-IFN synergizes with mouse beta-IFN or alpha-IFN in
inhibiting cell proliferation (Fleischmann, 1982). The
Important discoveries were that IFN treatment can block
stimulation of quiescent cells by serum (Sokawa et al.
,
1977) or by growth factors (Lin et al.
, 1980).
A mechanistic approach was pursued to elucidate the
action of IFN. Several lines of evidence were reported in
support of that IFN inhibited DNA synthesis indirectly.
First, IFN decreased the activity of DNA polymerase in
glioma cells (Lundblad & Lundgren, 1981). As a result,
cells were trapped in S phase in the cell cycle and
completion of DNA replication is delayed. Second, in
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IFN-treated Daudi cells, short Okazaki fragments, which
are essential components in discontinuous DNA synthesis,
accumulated and were delayed in formation of longer
fragments (Moore et al.
, 1984). IFN is also effective in
inhibiting certain activities of the transformed cells.
IFN decreases the levels of RNA transcribed from
c-Has-ras transfected 3T3 cells (Samid et al. , 1984) or
from c-has-ras and src genes in human bladder carcinoma
cells (Soslau et al.
, 1984). Expression of c-myc is also
affected by the IFN treatment (Kelley et al
.
, 1983).
However, It is difficult to pinpoint whether the
expression is the cause or effect of growth inhibition
(Clemens & McNurlan, 1985).
Other Antiproliferative Substances
Growth inhibitors, which are peptide in nature, are
only a subset of the family of antiproliferative
molecules. Different molecules from senescent and
quiescent human diploid fibroblasts were isolated
(Pereira-Smith et al.
, 1985). These molecules which are
membrane-associated proteins inhibit DNA synthesis.
Interestingly, suppression of tumorigenicity was
described in hybrids of normal and oncogene-transformed
Chinese hamster embryo fibroblast cells (Craig &Sager,
1985), suggesting an inhibitory mechanism. Growth
inhibitor, which is carbohydrate (Castellot et al .
,
1986) or lipid ( Stall cup et al.
, 1984) in nature, has been
described very recently. Further characterization of
these molecules, however, remains to be done.
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Dual Control of Cell Growth
The major point of this model is that cell
proliferation is controlled by two elements: a positive
growth factor and a negative growth factor.
Proliferation of normal cells requires exogenous growth
factors for optimal growth (Temin, 1970). Transformed
cells, on the contrary, are not under the control of
exogenous growth factors. That fewer exogenous growth
factors are needed for growth accounts for the relatively
autonomous nature of transformed cells and is indicative
of defective growth control. Previously, it was shown
that many human tumor cells produced growth factor-like
molecules constitutively (Heldin & Westermark, 1984). It
may well be that transformed cells produce and respond to
their own "growth factors" (Heldin & Westermark, 1984).
Several important experiments confirmed this
possibility. High concentrations of bombesin were
detected in human small cell lung carcinomas (Moody et
al
. ,
1981 ) and bombesin can support growth of the cells in
serum-free medium (Carney et al . , 1983). Antibodies
specific to bombesin inhibited growth of these cells in
vltro and in xenograft form in nude mice ( Cuttitta et al .
,
1985). The responsiveness of cells to growth factors can
also explain some actions of growth factors. Some
transformed cells are less sensitive to the negative
growth factors (Kinders & Johnson, 1982; McMahon et al
.
,
1982). Antagonism between positive and negative growth
factors may occur in the culture medium or in binding to
the surface receptors or even in the post-receptor
signaling pathway (Sporn & Roberts , 1985). Defects at any
of these levels may lead to cell transformation. A
critical role for the growth inhibitor, however, remains
-15-
to be established.
Effects of TPA on Cells in Culture
Sivak and Van Duuren (1967) showed that croton resin
enhanced focus formation of 3T3 cells in culture. TPA was
later shown to be the compound with the highest tumor
promoting activity in mouse skin (Hecker, 1978). The
pleiotropic effects of TPA were documented in diverse
cell types in culture (Diamond et al . , 1980). Caution
must be taken, however. Many of these findings were not
necessarily indicative of the promoting activity of TPA.
Rather, these studies described the effects of TPA on
cell proliferation and differentiation. Fisher et al .
,
(1978) described that TPA increased 2-3 fold the number
of transformed foci in rat embryo cell cultures infected
with adenovirus type 5. Mondal and others (1976)
established the protocol for two-stage transformation in
cell culture which was analogous to two-stage
carcinogenesis in mouse skin.
O'Brien (1976) described the induction of ornithine
decarboxylase (ODC), the rate-limiting enzyme in
polyamine synthesis, with a 200-fold increase in
activity stimulated by TPA. In addition, the induction of
ODC was correlated well with the promoting activity of
different doses and non-phorbol tumor promoters in the
epidermis. Also, TPA was used to induce ODC activity in
Swiss 3T3 cells and similar results were obtained
(Butler-Gralla and Herschman, 1983). TPA stimulated DNA
synthesis in stationary human fibroblasts and mouse
fibroblasts (O'Brien et al. , 1979; Mondal et al. , 1976).
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In particular, Bynergism between TPA and epidermal
growth factor, insulin or fibroblast growth factor in
stimulating DNA synthesis has been described (Disker &
Rozengurt, 1978). Recently, Niedel et al. (1983)
described that protein kinase C was the cell surface
receptor for TPA. Phosphoinositol turnover was implied
in the signal transduction and diacylglycerol may be the
endogenous component which triggers the cascade of
signal transduction in response to an extracellular
stimulus (Nishizuka, 1984).
TPA enhanced oncogene-induced transformation in
C3H 10T1/2 cells and rat fibroblasts (Hsiao et al . , 1984;
Dotto et al
. , 1985; Hsiao et al . , 1986). The exact
mechanism of action of TPA on these cells is not clear.
Studies of chemical carcinogenesis, particularly tumor
promotion, have revealed some insights very recently.
Oncogenes in combination with TPA were used in the study
of cell transformation in vitro and tumor development in
vivo (Quintanilla et al.
, 1986; Brwon et al. , 1986) and
the critical role of TPA in the stage of promotion was
substantiated. TPA enhanced the incidence of the
transformed phenotype in both systems. These data indeed
suggested common pathways of tumor development from
viral origin or chemical origin.
17-
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II. INHIBITION OF CELLULAR DNA




, which was isolated from bovine
cerebral cortex cell surface, was shown to be a potent
inhibitor of DNA synthesis and cell division. The
inhibition of DNA synthesis could be measured as early as
5 h after the addition of the molecules to exponentially
dividing 3T3 cells. The inhibitory activity was
reversible and removal of the sialoglycopeptide led to a
burst of DNA synthesis that peaked far above the level of
DNA synthesis measured in rapidly dividing control
cultures. DNA synthesis could be inhibited for as long as
50 h, although a small proportion of the arrested cells
appeared to escape after 40 h. A comparable degree of
inhibition was evident when cell numbers in the treated
cultures were counted. The sialoglycopeptide also
inhibited DNA synthesis of human skin fibroblasts while
two mouse myeloma cell lines and mouse LM 22 cells were
less sensitive to the inhibitory activity. In contrast to
another cell surface inhibitor described previously
which could inhibit cell growth if the LM cells were
pretreated with gangliosides
, pretreatment with
ganglioside GDla did not convert LM cells to being
sensitive to the sialoglycopeptide in this study.
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INTRODUCTION
Cell proliferation Is regulated by a complex series
of interaction at the cell surface involving both growth
factors and growth inhibitors. Cells propagated in
culture become quiescent at confluency (Pardee et al.
,
1978) and can be stimulated to traverse the cell cycle by
a number of mitogenic agents which presumbly activate
kinases, alter ion fluxes, or activate oncogenes (Heldin
and Westermark, 1984; Martin et al
.
, 1984; Sporn and
Roberts, 1985). In addition to the stimulation of cell
division by growth factors , DNA synthesis and division of
proliferating cells can be inhibited by addition of cell
membrane fragments and solubilized membrane components
(Whittenberger and Glaser, 1977; Whittenberger et al .
,
1978; Wieser et al
. , 1985). Although work on cell growth
factors has been extensive, relatively few studies on
purified growth inhibitors emerged. Purification and
characterization of these cell surface components have
been difficult even though growth inhibitors have been
identified from a wide variety of tissues and cells. Most
of these inhibitors appeared to be proteins or
glycopeptides and have been identified from mouse and
bovine brain (Kinders et al. , 1980; Kinders and Johnson,
1982; Charp et al. ,1983), liver (McMahon et al . , 1982),
platelet (Brown and Clemmons, 1986), mammary gland
(Bohmer et al
. , 1986,) and recovered from cell culture
media (Holley et al
. , 1980; Hsu and Wang, 1986). Since
most of these inhibitors have not been purified to
homogeneity, the sites and mechanism of action remain
unclear.
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We previously described the isolation and
purification of a sialoglycopeptide from bovine cerebral
cortex cell surface membrane that was a potent inhibitor
of both DNA synthesis and protein synthesis in a variety
of cells grown in culture (Sharifi et al
.
, 1986a). The
sialoglycopeptide has been purified to homogeneity and
shown to have a molecular weight of 18 , 000 and pi 3.0. The
inhibitor decreased both protein and DNA synthesis at the
intracellular level; uptake of radiolabelled precursors
were not affected. Binding of the sialoglycopeptide to
target cells involved specific, high affinity cell
surface receptors and the Inhibition of protein
synthesis was correlated with receptor occupancy (Bascom
et al.
, 1986).
In this communication, we describe the kinetics of
inhibition of DNA synthesis of 3T3 cells by the
sialoglycopeptide and the reversible nature of the
inhibition following its removal. In addition, the
sensitivity of several nontransformed and transformed
target cells to the inhibitor were compared.
-26-
MATERIALS AND METHODS
Isolation and purification of bovine sialoglycopeptide
The bovine sialoglycopeptide was purified to
homogeneity as described elsewhere (Sharif! et al .
,
1986a). Briefly, the bovine cerebral cortex cell
suspensions were treated with pronase at a final
concentration of 0.02 unit/ml (Sigma Chem. Co., St.
Louis, MO). The supernatant fluid was collected and
precipitated with 95* ethanol . The precipitate was
suspended in distilled water and extracted with
choloroform/methanol (2/1, v/v) and lyophilyzed to
dryness. Then the material was purified by
diethylaminoethyl (DEAE) ion exchange chromatography,
wheat germ agglutinin affinity chromatography, size
exclusion high pressure liquid chromatography (HPLC) and
hydroxyapatiteHPLC (Bascom et al . , 1986).
Cell culture
Swiss 3T3 cells (American Type Culture Collection,
Rockville, MD) and human foreskin fibroblasts (HSBP)
(from Dr. Paul Charp, Oak Ridge National Laboratories,
TN) were grown at 37°C in Dulbecco's modified Eagle's
medium (Gibco Laboratories, Grand Island, NY) plus 10#
calf serum (Hazleton, Denver, PA) and maintained in a
humidified atmosphere of 5% C02 /95# air. Cells were
plated at 5 x 10 cells/cm2 in 24-well plates (Costar,
Cambridge, MA) and allowed to grow for 24 h. Cells at the
density of approximately 1.0 x 10 4 cells/cm2 were then
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incubated with the sialoglycopeptide as described in
individual experiments.
Mouse LM 22 cells obtained from Dr. David Rintoul
,
Kansas State University, were plated and grown under
similar conditions to that for 3T3 cells except in
Eagle's minimal essential medium (Flow Laboratories,
McLean, VA) plus 556 fetal calf serum (KC Biological,
Lenexa, KS).
Myeloma X63-Ag8 (Ag8) cells (American Type Tissue
Collection, Rockville, MD) and myeloma Fox-NY cells
(HyClone Laboratories, Logan, UT) were grown in
conditions similar to that for LM cells except 1095 fetal
serum was added and cells were maintained in a humidified
atmosphere of 10?S C02 /905& air.
Measurement of DNA synthesis
After incubation with the sialoglycopeptide, the
culture medium was removed and DNA synthesis was measured
by incubation with 0.2 ml of medium containing 2 . uCi of
[ H]thymidine (Adjusted with thymidine to a specific
activity of 0.5 Ci/mmole) ( ICN Radiochemicals , Irvine,
CA) for 1 h. After incubation the medium was removed and
the cells were solubilized in 1 ml of 0.2 N NaOH.
Macromolecules were precipitated with 1 ml of 20#
trichloroacetic acid (TCA) and 0.1 ml of 195 BSA as a
carrier and centrifuged at 2,000 x g for 7 min. The
pellets were washed with 2095 TCA and the precipitates
were collected by centrifugation. The precipitates were
suspended in . 2 ml of 1 N NaOH and . 1 ml al iquots of the
samples were mixed with 2.5 ml scintillation cocktail and
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the radioactivity was measured.
Ag8 and Fox-NY cells were grown in suspension and
DNA synthesis was measured by adding 7.5 uCi of
[ H]thymidine in 20 ul of medium to the cells and
incubated for 1 h after treatment with the
sialoglycopeptide. Cells were then transferred to tubes
and processed in the same way as for 3T3 cells described
above.
Determination of cell number
After incubation of 3T3 cells with the bovine
sialoglycopeptide, cells were detached by trypsin and
diluted in Isoton II (Coulter Electronic Inc., Hialeah,
FL). The number of cells was counted with Coulter counter
model Zf (Coulter Electronic Inc., Hialeah, FL )
.
Inhibition of cell growth was calculated as follows
:
(%) Inhibition of cell growth = 10096 x
increase in cell number in inhibitor group
( 1 - _ )
increase in cell number in untreated group
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RESULTS
To measure the ability of the sialoglycopeptide to
inhibit DNA synthesis in exponentially growing 3T3
cells, we incubated the cells with various
concentrations of the peptide in complete medium and 2.596
calf serum as described in Materials and Methods.
Following a 20-h incubation period, DNA synthesis was
determined and compared with DNA synthesis in untreated
control cultures by incubation with [
3
H] thymidine. A
dose-dependent inhibition of DNA synthesis was observed.
A 25* decrease of DNA synthesis with 40 ng/ml of the
sialoglycopeptide and a maximum of 35* inhibition with 80
ng/ml of the sialoglycopeptide were observed (Fig. 1 )
.
As 3T3 cells were incubated with 40 ng/ml of the
sialoglycopeptide for a prolonged period, DNA synthesis
of the cells continued to decline until 30-h when it
reached approximately 50* of that measured in
exponentially growing cell cultures (Fig. 2). The
inhibitory activity was shown to be nontoxic and
reversible when cells were incubated with 40 ng/ml of the
sialoglycopeptide for 20 h. Upon removal of the inhibitor
an increase in DNA synthesis was shown at a higher rate
than that of untreated exponentially growing 3T3 cell
cultures (Fig. 2). Approximately 10 h after removal of
the sialoglycopeptide, DNA synthesis of the cells was
150* to 160* of that measured in rapidly dividing 3T3 cell
cultures. The kinetics of reversal and the peak of DNA
synthesis followed by a sharp decline indicated that a
significant fraction of the cell population was arrested
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and synchronized by the sialoglycopeptide (Fig. 2).
The kinetics of inhibition of DNA synthesis was
demonstrated with 40 ng/ml of the sialoglycopeptide and
the decrease in DNA synthesis could be measured
throughout 40 h with a single addition of the inhibitor
(Fig. 3). By 50 h, however, a small fraction of the cells
appeared to escape the inhibition since the rate of DNA
synthesis began to increase slightly, even in the
presence of the sialoglycopeptide (Fig. 3). The escape of
these cells could not be prevented by the addition of a
fresh aliquot of the inhibitor, suggesting that the
escape was not a result of depletion or inactivation of
the sialoglycopeptide initially added.
To be certain that the treatment of the
sialoglycopeptide also give rise to mitotic arrest, we
incubated exponentially growing 3T3 cells with 40 ng/ml
of the peptide. The numbers of cells were counted
following 24 h and 48 h of incubation and compared to
cultures to which the inhibitor was not added, Cell
division was clearly inhibited by the sialoglycopeptide
since treated cultures showed a 40# reduction in cell
number 24 h after the addition of the sialoglycopeptide
(Table 1). Similar to the results in figure 3, an escape
of a fraction of the arrested cells was evident after 48 h
of incubation with the inhibitor since the reduction in
cell number was only 30# of that measured in untreated
control cultures (Table 1).
The ability of the sialoglycopeptide to inhibit
transformend cell lines and human skin fibroblasts was
tested by incubating the cells with 20 ng/ml and 40 ng/ml
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of the molecules for 20 h. Human skin fibroblasts were at
least as sensitive as 3T3 cells to the slaloglycopeptide.
(Table 2 )
.
In contrast, transformed cells of Ag8 myeloma
and Fox-NY myeloma were less sensitive to the inhibitory
activity at both concentrations of the molecules. Mouse
LM 22 cells, which are devoid of cell surface
gangliosides, also were refractory to the inhibitory
activity of the slaloglycopeptide. However, LM cells
became sensitive to another cell surface-derived
glycopeptide growth inhibitor isolated from bovine
cerebral cell surface after these cells were pretreated
with gangliosides (McGee et al . , 1983; Bascom et al .
,
1985). In the present study, the pretreatment with
ganglioside GDla did not convert the LM cells to a




Although there is little question that integral
cell surface components play an important role in
cell-cell communication and growth control, the
hydrophobic nature of many membrane-associated proteins
and glycopeptides has made their isolation and
purification a difficult task. As a result, biologically
relevant cell surface macromolecules , that may function
as inhibitors of cell metabolism and division, and their
receptors have not been characterized. Most studies
concerning growth inhibitors, therefore, have been
restricted to the detection and titration of their
biologically inhibitory activity (Whittenberger and
Glaser, 1977; Lieberman et al . , 1981;Bohmer et
al.,1984). In this report, we did not starve or deprive
the cells of serum throughout the experiments and
observed growth inhibition. We want to emphasize that the
conditions we used may reflect or relate to the
physiological relevance of this growth inhibitor.
Previous studies with this sialoglycopeptide
focused on its ability to inhibit protein synthesis in a
variety of target cells and it was shown that binding of
the sialoglycopeptide to the cell surface receptors was
sufficient to mediate inhibition of protein synthesis
while the ligand did not have to be internalized (Sharifi
et al
. ,
1986b). The present study shows that the
sialoglycopeptide is a potent inhibitor of DNA synthesis
as well as cell division of nontransformed cells (Fig 1
and Table 1). Similar patterns of inhibition of DNA
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synthesis or cell division were described by others as
well (Charp et al. , 1983; Hsu and Wang, 1986; Brown and
Clemmons, 1986). DNA synthesis remained inhibited for at
least 40 h when the Inhibitor was maintained in the
culture medium but removal of the sialoglycopeptide led
to recovery of the cells from growth arrest (Fig. 2 )
.
The reversible and nontoxic nature of inhibition of
DNA synthesis by the sialoglycopeptide was similar to
that observed with another glycopeptide inhibitor
previously studied (Charp et al., 1983). One might argue
that the burst of DNA synthesis was due to the addition of
fresh medium containing serum factors. We rule out this
possibility of serum stimulation. First, we could not
find any increase in DNA synthesis upon addition of fresh
medium to those logarithmically growing cells (control
group) in the same data. Second, we could not detect any
increase in DNA synthesis by adding fresh medium to
logarithmically growing cells at 10 h interval for 30 h
(data not shown). However, unlike the glycopeptide
inhibitor that arrested cells In Gg phase of the cell
cycle, the kinetics of inhibition suggested that the
sialoglycopeptide blocked the cells in the G.^ phase or
Gj^/S boundary (Fig. 1 and Fig. 2). Cells remain arrested
(measured by cell number) for at least 10 h after removal
of the inhibitor (unpublished observation). These cells
have generation time about 17 h. Another feature that
distinguishes these two inhibitors is associated with
the sensitivity of LM cells to these two growth
inhibitors. LM cells when pretreated with gangliosides
were converted from a resistant state to a sensitive
state to the glycopeptide (McGee et al. , 1983; Bascom et
al
.
, 1985) while LM cells remained refractory to the
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sialoglycopeptide after incubated with ganglioside GDla
(Table 2).
These results are consistent with the possibility
that cell surface components mediate growth regulation
through cell-cell contact (Whittenberger and Glaser,
1977; Bielka et al
. , 1986; Hermann and Grosse, 1986;
Wieser and Oesch, 1986) and events that lead to cell
transformation may render the cells refractory to the
inhibitory molecules (Kinders and Johnson, 1982; Sharifi
et al
. ,
1986a). It is not clear that transformed cells
lack specific receptors for the sialoglycopeptide or are
defective in the process of signal transduction.
•35-
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Table 1. Inhibition of cell division by a
bovine sialoglycopeptide
Incubation Time Control Cultures Sialoglycopeptide Treated Inhibition
4(h) (number of cells x 10 ) (%)
0.8 + 0.3 0.8 + 0.2
24 1.9 + 0.2 1.3 + 0.2 40
48 5.2 + 0.1 3.9 + 0.2 30
3T3 cells were plated as described in Materials and
Methods. Following a 24-h period, 40 ng/ml of the
sialoglycopeptide was added to one set of cultures. The
cell number was determined in the control and
sialoglycopeptide-treated cultures after an incubation
period of 24 h or 48 h. Each determination of cell number
is reported as an average and range of duplicate
cultures.
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Each cell line was incubated with the
sialoglycopeptide for 20 h and DNA synthesis was compared
to similar cultures to which the inhibitor was not added.
Ganglioside GDla (3 ug/ml ) was added to LM 22 cells 3 h
prior to incubation with the sialoglycopeptide. The data
are reported as the average and range of two independent
determinations carried out in duplicate.
Fig. 1. Inhibition of DNA synthesis by a
sialoglycopeptide. 3T3 cells were treated with various
concentrations of purified bovine sialoglycopeptide
after they were allowed to attach for 24 h. Cells were
qtreated for 20 h and incubated with [ H]thymidine for 1 h.
Cellular DNA was precipitated twice with 2
trichloroacetic acid. DNA was then dissolved in 1 N NaOH
and radioactivity was determined by liquid scintillation
counting. The data were plotted as percent of DNA
synthesis in control cultures receiving 2.5# calf serum






Fig. 2. Reversal of the inhibitory effect of the
sialoglycopeptide. Cells were treated as in figure 1
except following 20 h incubation with 40 ng/ml of the
sialoglycopeptide, a set of cultures received fresh
medium indicated by the arrow. The other cultures were
not disturbed until assayed for DNA synthesis. The broken
line denotes the DNA synthesis in control cultures. The
open circles indicate the cultures fed with fresh medium
following 20 h incubation with the sialoglycopeptide.
The filled circles are the cultures treated with the
sialoglycopeptide throughout the experiments. The data















Fig. 3. Kinetics of inhibition of DNA synthesis. As
in figure 2, growing 3T3 cells were incubated with 40
ng/ml of the sialoglycopeptide for a total period of 50 h.
DNA synthesis was determined as indicated beginning in 5
h in triplicate cultures. The remaining cultures were not
disturbed until determination of DNA synthesis. The data
were graphed as percent of DNA synthesis in control






















III. A UNIQUE SIALOGLYCOPEPTIDE
GROWTH REGULATOR THAT





The ability of a naturally occurring cell surface
sialoglycopeptide growth inhibitor to antagonize the
induction of DNA synthesis by the tumor promoter
12-0-tetradecanoylphorbol-13-acetate (TPA) was studied
with mouse 3T3 cells. The bovine sialoglycopeptide was
shown to be a potent antagonist of TPA-stimulated DNA
synthesis in confluent 3T3 cell cultures. Kinetic
studies demonstrated that inhibition of TPA- induced DNA
synthesis required the addition of sialoglycopeptide
within 15 min of TPA treatment. Addition of the
sialoglycopeptide 30 min or longer after the cells were
exposed to TPA did not block stimulation of DNA synthesis
by TPA. The inhibition of TPA action was shown not to be
restricted to DNA synthesis in 3T3 cells since the
sialoglycopeptide also inhibited TPA-induced ornithine
decarboxylase (ODC. L-ornithine carboxylase, EC
4.1.1.17) activation in suspensions of mouse epidermal
as well as 3T3 cells.
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INTRODUCTION
TPA is a potent tumor promoter and experiments with
the phorbol ester in the mouse skin system have provided
the strongest evidence for two-stage carcinogenesis
(26). This experimental model has been used extensively
to study the mechanisms of tumor promotion and led to the
use of TPA in studies of cell transformation in culture
(9, 11). The addition of TPA to cell cultures has been
shown to have numerous effects on cell proliferation,
virus replication and cell morphology (7, 8, 11, 28).
Although the mechanism of TPA action is not fully
understood, protein kinase C appears to be the cell
surface receptor for the phorbol ester (1). The process
of signal transduction between TPA-induced
phosphorylation of cellular proteins and the induction
of DNA synthesis involves cascade reactions that remain
to be studied.
We have described a cell surface sialoglycopeptide
from bovine cerebral cortex cells which was shown to
inhibit both protein synthesis and DNA synthesis in
nontransformed cells (25). Many transformed cells are
relatively resistant to the inhibitory activity. The
inhibitor did not have to be internalized to exert the
inhibitory activity (23) and the inhibition is nontoxic
andreversible(Chou et al
. ,
in preparation ). Inaddition
,
the sialoglycopeptide did not alter the uptake of
radioactive precursors (25). This sialoglycopeptide is
very likely a candidate for studying the antagonism of
some TPA-induced effects. The ability of a growth
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inhibitor to block responses of the cells to tumor
promoter would be important since only a few agents have
been shown to inhibit TPA activities in vivo and in vitro .
These agents are, in general, free radical scavengers,
such as D-alpha-tocopherol or glutathione level raising
agents that enhance the activity of the glutathione





L-ornithine-HCl were purchased from Sigma Chemical Co.
(St. Louis, MO). DL-[l- 14C]-ornithine-HCl (specific
activity: 57.3 mCi/mmol) was obtained from New England
Nuclear (Boston, MA) and [methyl-3H] thymidine (specific
activity: 0.5 Ci/mmol) from ICN Radiochemical (Irvine,
CA).
Isolation and Purification of Sialoglycopeptide
The sialoglycopeptide was isolated from bovine
cerebral cortex cell surface and purified as described
previously (25). Briefly, the sialoglycopeptide was
released from cortical cells by mild pronase treatment,
precipitated with ethanol , extracted by
chloroform/methanol (2/1, v/v) and dialyzed prior to
lyophilization. The sialoglycopeptide was purified by
diethylaminoethyl ion exchange chromatography, wheat
germ agglutinin chromatography and size exclusion high
pressure liquid chromatography.
Cell Culture
Swiss 3T3 cells were grown in culture in a
humidified incubator with 5% C02 /95# air atmosphere. The
TPA nonresponsive TNR-2 and TNR-9 cell lines were kindly
provided by Dr. H. Herschman, University of California,
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CA. Cells were plated in 24-well plates from Costar
(Cambridge, MA) and allowed to grow to confluent prior to
experiments with TPA. TPA was dissolved in
dimethylsulfoxide (DMSO) and diluted in Dulbecco's
Modified Eagle's Medium (DMEM) containing 2.556 calf
serum and filter-sterilized. The final volume added to
3T3 cells was 0.2 ml containing 0.156 DMSO (v/v) and the
control cultures were incubated with . 196 DMSO only.
Preparation of Mouse Epidermal Cells
Female CF-1 mice from Sasco Inc. (Omaha, NE) at age
7-9 weeks were used; suspensions of isolated mouse
epidermal cells were prepared by trypsin digestion as
described elsewhere (19). Approximately 2 x 106 viable
cells were suspended in 0.8 ml of serum-free modified
Eagle's medium containing 25mM
N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid
(HEPES) buffer (pH7.0).
Measurement of DNA synthesis
DNA synthesis was measured as described elsewhere
(25). Briefly, the medium was replaced with 0.2 ml of
fresh DMEM that contained 2.596 calf serum and 2.0 uCi of
[ H]thymidine and incubated for 1 h. Cells were washed
three times with HKM buffer (10 mM HEPES, 120mMKCl, 5mM
MgCl 2 ; pH 7.1) and cells were disrupted with 0.5 ml of 0.2
N NaOH. DNA was precipitated with 0.5 ml of 20S6
trichloroacetic acid (TCA) at l,000g for 10 min. The
precipitates were washed two times with 1096 TCA and
centrifuged. The final precipitates were suspended in
0.5 N NaOH. Fractions were mixed with scintillation fluid
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and radioactivity was determined.
Measurement of ODC
Mouse epidermal cells were incubated with 62 ng/ml
of TPA in serum-free medium as described above for 5 h.
Cells were frozen and thawed three times and ODC activity
was determined in 0.2 ml aliquots of the clear
supernatants as described before (19). Assays were
carried out in triplicate and values were corrected by
use of no enzyme or boiled enzyme blanks. The results were
expressed as nmoles of C02 released in 60 min per 2 x 10
6
cells. 3T3 cells were manipulated in a similar manner.
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RESULTS
In order to measure the magnitude of TPA-induced DNA
synthesis in confluent 3T3 cells, various concentrations
of TPA were incubated with the cells for 24 h. DNA
synthesis was then measured. DNA synthesis was
stimulated with the maximal stimulation of 7-8 fold in
the range of 50 ng/ml to 100 ng/ml of TPA in agreement with
results reported by others (4, 6). The possibility of
antagonism between the sialoglycopeptide and TPA was
then tested. 3T3 cells were incubated with 50 ng/ml of TPA
in combination with various concentrations of the
sialoglycopeptide for 18 h and DNA synthesis was
determined. The presence of 40 ng/ml of the
sialoglycopeptide in the incubation medium reduced DNA
synthesis by 40# and 80 ng/ml by 90£ as compared to
TPA-induced DNA synthesis (Figure 1).
The kinetics of inhibition of the TPA effect by the
sialoglycopeptide was studied. 3T3 cells were treated
with the sialoglycopeptide at various time points
following incubation with TPA. Addition of 80 ng/ml of
the sialoglycopeptide and 50 ng/ml of TPA simultaneously
to the cells blocked TPA-induced DNA synthesis by 8795
(Figure 2). Only 70% reduction of DNA synthesis was
observed with 15 min delay of the sialoglycopeptide
treatment following exposure to TPA. Furthermore,
addition of the sialoglycopeptide to the cells 30, 60, or
150 min after exposure to TPA had no effect on the
mitogenic activity of TPA (Figure 2). These data
indicated the antagonism between TPA and the
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sialoglycopeptide occurred in the early steps of signal
transduction.
The possibility of shared cell surface receptors
between TPA and the sialoglycopeptide was examined.
Radio-labeled sialoglycopeptides were incubated with
3T3 cells in the presence of increasing concentrations of
TPA. The level of binding was not affected by increasing
concentrations of TPA as high as 300-fold in excess (in
moles) over the sialoglycopeptide (data not shown).
Clearly the two ligands did not share the same receptors,
implying that the antagonism occurred in the process of
signal transduction. The same conclusion was drawn in the
experiments with TPA nonresponsive cell lines TNP-2 and
TNR-9. These two cell lines did not initiate mitogenic
response after binding to TPA (4) while both cell lines
responded to the sialoglycopeptide in inhibition of
protein synthesis to a similar extent as measured in the
parental 3T3 cells ( data not shown )
.
In most cells, elevated levels of polyamines were
observed in response to a growth stimulus (12, 13). In
order to measure ODC activity, we incubated the mouse
epidermal cells with 62 ng/ml of TPA for 5h, conditions
which resulted in the maximal stimulation of ODC activity
(19). The TPA-induced ODC activity was sensitive to the
sialoglycopeptide and as little as 60 ng/ml of the
sialoglycopeptide reduced the enzyme activity by 50#
(Figure 3). In contrast to the inhibition of TPA-induced
DNA synthesis, no further decrease in the ODC activity
was observed with increasing concentrations of the
sialoglycopeptide. Similar results were obtained when
ODC activity was measured in 3T3 cells (Table I).
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Incubation of 40 ng/ml of the sialoglycopeptide
inhibited TPA-induced ODC activity by 4096 similar to the
inhibition observed in the epidermal cells (Figure 3).
However, the addition of the sialoglycopeptide 1 h after




The results of this paper show that the bovine
sialoglycopeptide is a potent inhibitor of TPA action.
The sialoglycopeptide inhibited both TPA-induced DNA
synthesis and ODC activity (Figures 1 and 3) and the
kinetics of antagonism showed that the counteraction was
rapid (Figure 2). This conclusion was supported by the
results of ODC activity (Table I). The data strongly
suggested that the sialoglycopeptide interfered with TPA
action at early stage of TPA-induced signal
transduction. ODC activity in epidermal and 3T3 cells was
inhibited by approximately 40% with 60 ng/ml of the
sialoglycopeptide. Unlike the counteraction of DNA
synthesis, however, increasing concentrations of the
sialoglycopeptide did not result in further inhibition
of ODC activity. The fraction of ODC activity that
remained refractory to the action of the
sialoglycopeptide might reflect the de novo synthesis of
the enzyme which was probably not subjected to TPA
induction.
TPA synergized with a number of serum factors in
stimulating DNA synthesis (10). Thus, it is possible that
the sialoglycopeptide in effect blocks the activity of
other serum factors. We rule out this possibility. For
instance, measurement of ODC activity was carried out in
the absence of serum in the epidermal system and that
inhibition of TPA-induced ODC activity by the
sialoglycopeptide was direct. In addition, the
sialoglycopeptide inhibited bombesin-induced DNA
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synthesis in the absence of serum (Sharifi et al . , in
preparation)
.
The kinetic studies suggested that the
sialoglycopeptide intervened at the TPA-induced early
steps of signal transduction. It has been shown that
protein kinase C is the receptors for TPA and that TPA
activates protein kinase C, which in turn leads to
phosphorylation of other proteins. In addition, TPA
stimulated ion flux transport systems that include
Na /H antiport and Na+/K+ pump (14,29). It is likely
that the sialoglycopeptide interferes with either the
activity of protein kinase C, the activation of ion
transport systems or both.
The findings in this paper show that a cell surface
growth inhibitor can antagonize the mitogenic activity
of a phorbol ester tumor promoter. The data suggested
that the counteraction of TPA-induced mitogenesis did
not involve a direct competition between TPA and the
sialoglycopeptide for cell surface receptors and the
interaction occurred at the post-receptor level. These
observations are consistent with the proposition that
cell growth is regulated by growth inhibitors as well as
growth factors (27) and that cell transformation could
result from an imbalance in growth regulating signals
mediated at cell surface.
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Table I. The Sialoglycopeptide Inhibits
TPA-Induced ODC Activity in 3T3 Cells
Treatment ODC Activity ODC Activity













3T3 cells were incubated with 62 ng/ml of TPA alone
or TPA plus 40 ng/ml of the sialoglycopeptide. The
sialoglycopeptide was added to TPA treated cells either
simultaneously (0 time) or 1 h later and ODC activity was
determined. The data represent the average and range for
triplicate determinations.
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Fig. 1. Antagonism of TPA-induced DNA synthesis by
the bovine sialoglycopeptide. Confluent 3T3 cells were
treated simultaneously with 50 ng/ml of TPA and
increasing concentrations of the sialoglycopeptide for
18 h and thymidine incorporation was measured. The basal
3level of [ H] thymidine incorporation by confluent 3T3
cells (in the absence of TPA) is indicated by the open
circle on the ordinate and the broken line. The results
represent the mean and the range for each concentration






Fig. 2. Kinetics of inhibition of TPA-induced DNA
synthesis by the sialoglycopeptide. 3T3 cells treated
with TPA (50 ng/ml) alone (open bars) or TPA plus the
sialoglycopeptide (80 ng/ml) (shaded bars), the
sialoglycopeptide was added simultaneously (panel A) or
15 min (panel B) or 30 min (panel C) or 60 min (panel D) or
150 min (panel E) after TPA and incubated for 20 h.
Thymidine incorporation was then measured. The data





Fig. 3. Inhibition of TPA-induced ODC activity by
the sialoglycopeptide. Mouse epidermal cells were
incubated with 62 ng/ml of TPA and increasing
concentrations of the bovine sialoglycopeptide for 5 h
and ODC activity was determined. The results represent
the mean and range of triplicate from two independent
experiments. The basal level of ODC activity (in the
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Sialoglycopeptides purified from the bovine
cerebral cortex cell surface were incubated with various
lines of cells in logarithmically growing phase. The
purified material exhibited inhibitory activity on DNA
synthesis of nontransformed cells, whereas transformed
cells were refractory to the molecules. Also 3T3 cells
were blocked in cell division. LM 22 cells upon
pretreatment with ganglioside GDla remained refractory
to the inhibitory activity. The nontoxic nature of the
molecules was demonstrated upon removal of the material
from the cells. The data suggested that these cells were
arrested in G
± phase or G^ys boundary of the cell cycle.
The sialoglycopeptide counteracted the TPA-induced
DNA synthesis and ornithine decarboxylase activity in
3T3 cells. Studies of the kinetics of antagonism
indicated that interactions between these two species
occurred in the early steps of signal transduction. The
sialoglycopeptide decreased TPA-stimulated ornithine
decarboxylase activity in mouse epidermal cells as well
.
